Johns Hopkins HIV Guide
Adefovir
INDICATIONS
FDA
FDA
- Chronic hepatitis B in patients 12 years of age and older
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: July 8, 2018
Citation
Smith, Janessa M, and Paul A Pham. "Adefovir." Johns Hopkins HIV Guide, 2018. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545230/all/Adefovir.
Smith JM, Pham PA. Adefovir. Johns Hopkins HIV Guide. 2018. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545230/all/Adefovir. Accessed September 25, 2023.
Smith, J. M., & Pham, P. A. (2018). Adefovir. In Johns Hopkins HIV Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545230/all/Adefovir
Smith JM, Pham PA. Adefovir [Internet]. In: Johns Hopkins HIV Guide. ; 2018. [cited 2023 September 25]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545230/all/Adefovir.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Adefovir
ID - 545230
A1 - Smith,Janessa,Pharm.D., BCPS
AU - Pham,Paul,Pharm.D.
Y1 - 2018/07/08/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545230/all/Adefovir
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
